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ABSTRACT
Ca2C-permeable store-operated channels (SOCs) mediate Ca2C entry pathways which are
involved in many cellular functions such as contraction, growth, and proliferation. Prototypical
SOCs are formed of Orai1 proteins and are activated by the endo/sarcoplasmic reticulum Ca2C
sensor stromal interaction molecule 1 (STIM1). There is considerable debate about whether
canonical transient receptor potential 1 (TRPC1) proteins also form store-operated channels
(SOCs), and if they do, is Orai1 involved. We recently showed that stimulation of TRPC1-based
SOCs involves store depletion inducing STIM1-evoked Gaq/PLCb1 activity in contractile vascular
smooth muscle cells (VSMCs). Therefore the present work investigates the role of Orai1 in
activation of TRPC1-based SOCs in freshly isolated mesenteric artery VSMCs from wild-type (WT)
and Orai1¡/¡ mice. Store-operated whole-cell and single channel currents recorded from WT
and Orai1¡/¡ VSMCs had similar properties, with relatively linear current-voltage relationships,
reversal potentials of about C20mV, unitary conductances of about 2pS, and inhibition by
anti-TRPC1 and anti-STIM1 antibodies. In Orai1¡/¡ VSMCs, store depletion induced PLCb1
activity measured with the ﬂuorescent phosphatidylinositol 4,5-bisphosphate/inositol 1,4,5-
trisphosphate biosensor GFP-PLCd1-PH, which was prevented by knockdown of STIM1. In
addition, in Orai1¡/¡ VSMCs, store depletion induced translocation of STIM1 from within the cell
to the plasma membrane where it formed STIM1-TRPC1 interactions at discrete puncta-like
sites. These ﬁndings indicate that activation of TRPC1-based SOCs through a STIM1-activated
PLCb1 pathway are likely to occur independently of Orai1 proteins, providing evidence that
TRPC1 channels form genuine SOCs in VSMCs with a contractile phenotype.
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Introduction
Ca2C-permeable store-operated channels (SOCs) are
physiologically activated by stimulation of the classical
phosphoinositol signaling pathway involving Gaq-
coupled receptors coupled to inositol 1,4,5-trisphos-
phate (IP3)-mediated depletion of endo/sarcoplasmic
reticulum (ER/SR) Ca2C stores. In vascular smooth
muscle cells (VSMCs), SOCs mediate Ca2C entry
pathways which are proposed to regulate contractility,
proliferation and migration, and are considered thera-
peutic targets for cardiovascular diseases such as
hypertension and atherosclerosis.1-3 Identifying mole-
cules involved in the composition and activation
pathways of SOCs are therefore important objectives
in vascular biology.
It is ﬁrmly established that prototypical SOCs,
termed calcium release-activated channels (CRACs),
have properties of high Ca2C permeability, pro-
nounced inward rectiﬁcation, unitary conductances in
the fS range, and are composed of pore-forming Orai1
proteins.4 Activation of Orai1-based CRACs is
through stromal interaction molecule 1 (STIM1),
which senses Ca2C within ER/SR stores and following
store depletion undergoes oligomerisation and trans-
location near to the cytosolic surface of the plasma
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membrane (PM) where it interacts with Orai1 to
induce channel assembly and opening.4,5
It is also apparent that many cell types also express
SOCs which have very different characteristics to
Orai1-based CRACs such as much lower Ca2C perme-
ability, relatively linear rectiﬁcation, considerably
larger unitary conductances, and structures composed
of the canonical transient receptor potential family of
Ca2C-permeable non-selective cation channel proteins
(TRPC1-C7).6 TRPC1, TRPC3, and TRPC4 channels6
have been particularly implicated in composing SOCs,
but there are likely to be many distinct TRPC-based
SOCs as TRPC subunits can form diverse heteromeric
channel structures.7-9 Considerable controversy sur-
rounds the legitimacy of TRPC-based SOCs being
genuine channels activated by store depletion, since
there is uncertainty on whether TRPC subunits com-
pose the conducting pore of SOCs, and how store
depletion induces TRPC channel gating. This issue is
further supported by TRPC-based SOCs being pro-
posed to be activated or regulated by, or behave as
accessory proteins to, STIM1-activated Orai1-based
CRAC channels.6,10-16
In VSMCs, 2 different SOCs have been described
according to cell phenotype. In freshly isolated or pri-
mary cultured VSMCs with a contractile phenotype,
SOCs exhibit relatively linear rectiﬁcation, unitary
conductances of about 2pS, and are composed of a
heteromeric TRPC1/C5 molecular template that may
also contain other TRPC subunits.7-9, 17-20 As TRPC1
is the essential subunit which confers gating by store
depletion these heteromeric channel structures are
termed TRPC1-based SOCs.18-20 In long-term cul-
tured VSMCs which exhibit a non-contractile and
synthetic phenotype,21 multiple SOCs have been
described with both linear and highly inward rectiﬁca-
tion, which are reported to involve TRPC1 and
Orai1.22-28 In both contractile and synthetic VSMCs,
STIM1 has been proposed to mediate activation of
TRPC1-based and Orai1-based CRACs,20, 22-25, 28
which reﬂects the general consensus that activation by
STIM1 is a deﬁning feature of SOCs.11,12
Our recent ﬁndings have proposed that a STIM1-
activated phosphoinositol signaling pathway involving
Gaq, PLCb1, and PKC activities is essential for activa-
tion of native TRPC1-based SOCs in contractile
VSMCs.19,20 Store depletion induces STIM1 to trans-
locate from within the cell to the PM where if forms
STIM1-TRPC1 interactions, which stimulate Gaq/
PLCb1 activity to induce PKC-dependent phosphory-
lation of TRPC1 subunits and channel gating by phos-
phatidylinositol 4,5-bisphosphate (PIP2).
7-9, 17-20, 29,30
It is not known if Orai1 is involved in this activation
pathway, which is an important question if TRPC1-
based SOCs are to be considered genuine SOCs. The
present study investigates the properties of TRPC1-
based SOCs in contractile VSMCs from wild-type
(WT) and Orai1¡/¡mice. We identify that biophysical
characteristics and activation mechanisms of TRPC1-
based SOCs are unaltered in Orai1¡/¡ VSMCs, pro-
viding evidence that the composition and gating of
these SOCs are unlikely to require Orai1.
Results
Store-operated whole-cell and single channel cation
currents in WT and Orai1¡/¡ VSMCs
In our ﬁrst experiments, we compared the biophysical
properties and involvement of TRPC1 and STIM1 in
activation of store-operated whole-cell cation currents
in freshly isolated mesenteric artery VSMCs from WT
and Orai1¡/¡ mice. Figure 1A shows that end-point
PCR products run on an agarose gel were used to iden-
tify Orai1C/C, C/¡, ¡/¡ mouse genotypes as described
previously.31 Figures 1B & C show that passive deple-
tion of internal Ca2C stores following cell dialysis with
a patch pipette solution containing high concentrations
of BAPTA and no added Ca2C evoked whole-cell cation
currents in both WT and Orai1¡/¡ VSMCs, which had
similar mean amplitudes at all membrane potentials
tested, relatively linear current-voltage (I/V) relation-
ships, and reversal potentials (Erev) of about C20 mV.
In addition, Fig. 1B & C illustrate that bath application
of T1E3, a TRPC1 antibody which binds to a extracel-
lular pore region of TRPC1 and is known to act as a
channel blocker,7-9, 17-20, 32,33 and a putative extracellu-
larly-acting N-terminal STIM1 antibody,20,34, 35 both
inhibited store-operated whole-cell cation currents by
over 80% in WT and Orai1¡/¡ VSMCs. Moreover,
Fig. 1C demonstrates that in primary cultured Orai1¡/
¡ VSMCs, store-operated whole cation currents were
greatly reduced by knockdown of STIM1, using a
shRNA sequence previously shown to reduce STIM1
expression by over 80%.20
Figure 2A & B show that in WT and Orai1¡/¡
VSMCs, bath application of 1,2-Bis(2-aminophenoxy)
ethane-N,N,N0,N0-tetraacetic acid acetoxymethyl ester
(BAPTA-AM), a cell permeable Ca2C chelator, and
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the SR Ca2C-ATPase inhibitor, cyclopiazonic acid
(CPA) evoked single cation channel currents which
had similar mean NPo values at ¡80 mV and unitary
conductances between ¡50 mV and ¡120 mV of
about 2 pS in cell-attached patches. Fig. 2C also shows
that BAPTA-AM-evoked cation channel activities,
maintained following excision of cell-attached patches
into the inside-out conﬁguration, were reduced by
about 85% at ¡80 mV following bath application of
an intracellular-acting TRPC1 antibody in WT and
Orai1¡/¡ VSMCs.
These results indicate that store depletion induces
native TRPC1-based SOCs in contractile VSMCs as
described previously in mouse mesenteric arteries
and other vascular beds from different animal spe-
cies,7-9, 17-20, 29,30 and conﬁrms the importance of
STIM1 in activating these channels.20 Importantly,
these ﬁndings provide evidence that Orai1 is unlikely
to have a role in the composition or activation of
TRPC1-based SOCs.
Store depletion-induced PLCb1 activity in Orai1¡/¡
VSMCs
In a recent study we revealed that store depletion indu-
ces interactions between STIM1 and TRPC1, which
stimulate PLCb1 activity required for gating of native
TRPC1-based SOCs in contractile mouse and rabbit
VSMCs.19,20 In the next series of experiments we exam-
ined the role of Orai1 in this pathway by monitoring
store-operated PLCb1 activity in primary cultured
Orai1¡/¡ VSMCs following transfection with GFP-
PLCd1-PH, a ﬂuorescent biosensor with a high afﬁnity
for PIP2 and IP3
36,37, and measuring signal changes
(measured as relative ﬂuorescent units) at the PM (Fm)
and within the cytosol (Fc) as described previously.19,20
Figure 1. Store-operated whole-cell currents in freshly isolated mesenteric artery VSMCs from WT and Orai1¡/¡ mice A, Analysis of end-
point PCR products by agarose gel used to identify Orai1C/C, C/¡, ¡/¡ mouse genotypes. B, Representative recordings and mean cur-
rent-voltage relationships showing similar development and peak amplitudes of whole-cell cation currents induced by store-depletion
in WT and Orai1¡/¡ VSMCs, which are inhibited by T1E3. C, Representative recordings and mean data showing similar development
and amplitudes of whole-cell cation currents induced by store-depletion in WT and Orai1¡/¡ VSMCs, which were inhibited by an exter-
nally acting N-terminal anti-STIM1 antibody. In addition, in Orai1¡/¡ cells, transfection with STIM1 shRNA reduced the development
and amplitude of mean store-operated whole-cell cation currents. Each point from at least n D 6 patches and n D 3 animals,
p < 0.001 (control vs. at peak response), ###p < 0.001 (peak response vs. anti-STIM1 or shRNA STIM1).
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Figure 3A shows that in Orai1¡/¡ VSMCs, GFP-
PLCd1-PH signals were predominantly expressed at
the plasma membrane and had a mean Fm/Fc ratio of
about 7, reﬂecting the predominant cellular location
of PIP2. Bath application of BAPTA-AM induced
translocation of GFP-PLCd1-PH signals from the
plasma membrane to the cytosol with corresponding
reductions in mean Fm/Fc ratios, which were inhib-
ited by addition of the PLC inhibitor U73122. These
GFP-PLCd1-PH signal changes represent stimulation
of PLCb1 activity causing PIP2 hydrolysis at the
plasma membrane and subsequent generation of
cytosolic IP3.
19,20, 36,37 Fig. 3B demonstrates that
knockdown of STIM1 greatly reduced translocation of
GFP-PLCd1-PH signals induced by BAPTA-AM in
Orai1¡/¡ VSMCs. In contrast, stimulation of endoge-
nously expressed a1 Gaq-coupled adrenoreceptors by
bath application of noradrenaline induced transloca-
tion of GFP-PLCd1-PH signals from the PM to the
cytosol in the presence of STIM1 shRNA, suggesting
that STIM1 is not required for PLC activity per se as
described previously.20
These results indicate that store-operated STIM1-
evoked PLCb1 activity, pivotal to stimulation of
TRPC1-based SOCs in contractile VSMCs,19,20 occurs
in the absence of Orai1.
Store depletion-induced interactions between TRPC1
and STIM1 in Orai1¡/¡ VSMCs
Our studies propose that store-operated interactions
between TRPC1 and STIM1 are critical steps in stimu-
lation of Gaq/PLCb1 activity and activation of
TRPC1-based SOCs.19,20 We therefore investigated if
store-operated TRPC1 and STIM1 interactions occur
in Orai1¡/¡ VSMCs.
Figure 4A shows that in freshly isolated un-stimu-
lated Orai1¡/¡ VSMCs, immunocytochemical staining
Figure 2. Store-operated single channel currents in freshly isolated mesenteric artery VSMCs from WT and Orai1¡/¡ mice A & B, BAPTA-
AM and CPA evoked single cation channel currents with similar mean NPO values in cell-attached patches held at ¡80 mV, and similar
unitary conductances of about 2 pS between¡50 mV and¡120 mV in WT and Orai1¡/¡ VSMCs. C, Original traces and mean data show-
ing that BAPTA-AM-evoked single channel activity was inhibited by an intracellularly acting anti-TRPC1 antibody in WT and Orai1¡/¡
VSMCs. Each point from at least n D 6 patches and n D 3 animals, p < 0.001.
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Figure 3. Store-operated PLCb1 activity in Orai1¡/¡ mice A, In primary cultured Orai1¡/¡ VSMCs transfected with scrambled shRNA
(black), BAPTA-AM evoked translocation of GFP-PLCd1-PH-mediated signals from the PM to the cytosol (blue), which were inhibited by
U73122 (orange). B, In Orai1¡/¡ VSMCs transfected with shRNA STIM1 (black), BAPTA-AM-evoked translocation of GFP-PLCd1-PH signals
were reduced (blue). In these cells, noradrenaline (red) stimulated GFP-PLCd1-PH signals to translocate to from the plasma membrane
to the cytosol. Each point from at least n D 20 cells and n D 3 animals, p < 0.001.
Figure 4. Store-operated interactions between STIM1-TRPC1 in Orai1¡/¡ VSMCs A, Representative images from the same Orai1¡/¡ cell
showing staining for TRPC1 (green) and STIM1 (red) were predominantly present at the PM and located within the cytosol respectively.
B, In a different Orai1¡/¡ cell treated with BAPTA-AM, both TRPC1 and STIM1 were located at the PM in discrete puncta-like regions.
The inset image shows co-localization between TRPC1 and STIM1 staining (yellow) at the PM. Results taken from n D 3 animals.
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for STIM1 (red) was mainly located within the cytosol
whereas staining for TRPC1 (green) was predomi-
nantly found at the plasma membrane, and there were
few apparent regions of co-localization. Fig. 4B reveal
that pre-treatment with BAPTA-AM activated trans-
location of STIM1 signals from the cytosol to the PM,
and also stimulated co-localisations between TRPC1
and STIM1 (yellow) at discrete puncta-like sites.
These ﬁndings clearly indicate that store depletion
stimulates formation of STIM1-TRPC1 complexes at
the PM in the absence of Orai1.
Discussion
TRPC1 channels are ubiquitously expressed among
cell types, and are proposed to mediate a wide range
of physiologic and pathological functions.1 In VSMCs,
TRPC1-based SOCs mediate Ca2C entry pathways
which contribute to contractility, proliferation, and
migration, and are potential therapeutic targets for
cardiovascular diseases such as hypertension and ath-
erosclerosis.1-3 Therefore understanding the composi-
tion and activation mechanisms of TRPC1-based
SOCs are important aims.
There are still signiﬁcant discussions about whether
native TRPC-based SOCs exist in physiologic settings
including VSMCs, and if Orai1 subunits contribute to
the conducting pore or gating mechanism of these
channels.4,6, 10 The present study investigates these
goals in VSMCs with a contractile phenotype, and
reports that macroscopic and single channel proper-
ties of TRPC1-based SOCs are similar in contractile
VSMCs from WT and Orai1¡/¡. Moreover store-
operated STIM1-evoked PLCb1 activity and store
depletion-induced interactions between STIM1 and
TRPC1 previously shown to be obligatory for activa-
tion of TRPC1-based SOCs.19,20 are also maintained
in Orai1¡/¡ VSMCs. These ﬁndings indicate that the
composition and activation mechanism of TRPC1-
based SOCs in contractile VSMCs are unlikely to
require Orai1 subunits.
Our results show that in WT and Orai1¡/¡ VSMCs,
well-established store depletion protocols activated
whole-cell conductances with relatively linear I/V rela-
tionships and an Erev of about C20 mV and single
channel currents with a unitary conductance of about
2 pS, which were inhibited by TRPC1 and STIM1 anti-
bodies. These ﬁndings conﬁrm previous studies using
TRPC1¡/¡ cells and knockdown of STIM1 that
functional native TRPC1-based SOCs are expressed in
contractile VSMCs and that STIM1 is obligatory for
channel opening7-9, 17-20, 29,30 In recent pharmacologi-
cal and molecular studies, we showed that store deple-
tion stimulates interactions between STIM1 and
TRPC1 at the PM, which induces Gaq and PLCb1
activities and PKC-dependent phosphorylation of
TRPC1 proteins that is essential for channel open-
ing.19,20 Importantly, knockdown of STIM1 and use of
TRPC1¡/¡ cells prevented store-operated PLCb1
activity.20 In this study, we show that in Orai1¡/¡
VSMCs store-operated stimulation of PLCb1 activity
recorded using the PIP2/IP3 biosensor GFP-PLCd1-
PH.19,20, 36,37 was reduced by a PLC inhibitor, and pre-
vented by knockdown of STIM1. In agreement with
these results, immunocytochemical evidence identiﬁed
that store depletion stimulated translocation of STIM1
from within the cell to the PM, where it formed
STIM1-TRPC1 interactions at discrete puncta-like
locations at the PM in Orai1¡/¡ VSMCs. These data
reveal that Orai1 subunits are unlikely to contribute to
the conducting pore or activation mechanisms involv-
ing store-operated STIM1-evoked PLCb1 activity and
store-operated STIM1-TRPC1 interactions of TRPC1-
based SOCs in contractile VSMCs.
Orai proteins are composed of 3 subtypes, Orai1,
Orai2, and Orai3, which may all form Orai-based
CRACs4,38 It is therefore possible that Orai2 and
Orai3, and not Orai1, may be involved in TRPC1-
based SOCs in contractile VSMCs. However, store-
operated conductances with characteristics of
Orai2- and Orai3-based CRACs such as strong
inward rectiﬁcation and Erev >C50mV.4,38 were not
revealed in WT and Orai1¡/¡ cells when TRPC1-
based SOCs were inhibited with a TRPC1 antibody,
or in previous studies performed in TRPC1¡/¡
cells18,19,20 It will be important to further investigate
possible roles of Orai2 and Orai3 further using
knockdown approaches in WT and Orai1¡/¡
VSMCs. In addition, Orai-based CRACs may be
present in contractile VSMCs but produce small
irresolvable conductances using electrophysiological
recordings. A more effective approach might be to
investigate if Orai-based Ca2C sparklets, Ca2C entry
at localized regions of the PM due to opening of
Ca2C-permeable channels, are present using total
internal reﬂection ﬂuorescence microscopy.39
Store-operated Ca2C entry mediated by TRPC1,
Orai1, and STIM1, and a conductance with Orai1-
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based CRAC channel properties involving activation
by STIM1 have been identiﬁed in long-term cultured
VSMCs,22-28 which have a non-contractile, synthetic
phenotype that is considerably different from freshly
dispersed and primary cultured VSMCs with a con-
tractile phenotype used in the current study.21 Taken
together, the current evidence indicates that TRPC1-
based SOCs are present in contractile VSMCs,
whereas TRPC1-based SOCs and Orai1-based CRACs
are found in synthetic cells. This is in agreement with
low levels of Orai protein expression in contractile
VSMCs and much greater expression in synthetic
VSMCs.28,40 STIM1 activates both TRPC1-based
SOCs and Orai1-based CRACs in VSMCs, which sup-
ports the proposal that channel gating by store-oper-
ated activation of STIM1 is an important criterion for
deﬁning SOCs.11,12 Selective expression of TRPC1-
based SOCs and Orai1-based CRAC channels in dis-
tinct VSMC phenotypes may provide useful strategies
for developing therapeutic strategies to treat distinct
progression phases of cardiovascular diseases such as
hypertension and atherosclerosis.
This study provides further evidence that TRPC1-
based SOCs are expressed in native cells, and that
these channels do not require the presence of Orai1.
This provides a strong argument for the existence of
multiple SOCs composed of TRPC-based SOCs and
Orai-based CRACs, which can function independently
of one another.
Materials and methods
Reagents
Rabbit anti-TRPC1 antibody (T1E3) was generated by
GenScript (Piscataway, NJ, USA) using peptide
sequences from a previously characterized putative
extracellular region.1 Goat anti-TRPC1 (sc-15055),
goat anti-STIM1 (sc-79106), and secondary antibodies
were obtained from Santa Cruz Biotechnology (Dallas,
TX, USA). Rabbit anti-STIM1 antibody against the N-
terminal (11565–1-AP) was obtained from Protein-
tech (Chicago, IL, USA) while mouse anti-GOK/
STIM1 (610954) against the N-terminal was obtained
from BD Biosciences (Oxford, UK). All other drugs
were purchased from Sigma-Aldrich, or Tocris
(Abingdon, UK). Agents were dissolved in distilled
H2O or 0.1% dimethyl sulfoxide (DMSO). DMSO
alone had no effect on whole-cell currents or single
channel activity.
Genotyping
This was performed in accordance previous ﬁnd-
ings.31 For each mouse born to Cracm1C/¡ inter-
crosses, a 1–2 mm piece of tail was taken and treated
with 75 ml lysis solution containing 0.2 mM EDTA
and 25 mM NaOH with a pH of 12. The neutralizing
solution contained 40 mM Tris-HCl with a pH of 5.
Lysed tail-tips were heated at 95oC for 1h, cooled to
4oC, and then added to 75 ml neutralizing solution.
1 ml of this mixed solution was used as PCR
template. The genotyping protocol distinguished WT,
Orai1C/¡, and Orai1¡/¡ in a 3 primer PCR reaction.
Primer 1 (50- TCACGCTTGCTCTCCTCATC-30) is a
forward primer in intron 1, Primer 2 (50-
TAAGGGCGACACGGAAATG-30) is a forward
primer in the genetrap insert, and Primer 3 (50-
AGGTTGTGGACGTTGCTCAC-30) is a common
reverse primer in exon 2. WT mice produced a
488bp band while Orai1¡/¡ mouse produced a 300bp
band.
Cell isolation
WT and Orai1¡/¡ mice were killed using cervical dis-
location according to UK Animals Scientiﬁc Proce-
dures Act of 1986, and 2nd order mesenteric arteries
were dissected free, and cleaned of fat, connective tis-
sue and endothelium in physiologic salt solution con-
taining (mM): 126 NaCl, 6 KCl, 10 glucose, 11
HEPES, 1.2 MgCl2 and 1.5 CaCl2, pH adjusted to 7.2
using 10 M NaOH. Vessels were enzymatically dis-
persed into single VSMCs as described previously.18-20
Electrophysiology
Whole-cell and single-channel cation currents were
made with an AXOpatch 200B ampliﬁer (Axon
Instruments, Union City, CA, USA) at room tempera-
ture (20–23C) as described previously.18-20 Whole-
cell currents were ﬁltered at 1 kHz (¡3dB, low-pass 8-
pole Bessel ﬁlter, Frequency Devices model LP02,
Scensys, Aylesbury, UK) and sampled at 5 kHz (Digi-
data 1322A and pCLAMP 9.0 software, Molecular
Devices, Sunnydale, CA, USA). Whole-cell current/
voltage (I/V) relationships were obtained by applying
750 ms duration voltage ramps from C100 to
¡150 mV every 30 s from a holding potential of 0mV.
Single channel currents were ﬁltered between 0.1 kHz
and acquired at 1 kHz. Single channel I/V
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relationships were evaluated by manually altering the
holding potential of ¡80 mV between ¡120 and
C120mV.
Whole-cell recording bath solution contained
(mM): 135 mM Na-methanesulfonate, 10 mM CsCl,
1.2 mM MgSO4, 10 mM HEPES, 20 mM CaCl2,
10 mM glucose, 0.005 mM nicardipine, 0.1 mM 4,4-
diisothiocyanostilbene-2,2-disulfonic acid, and
0.1 mM niﬂumic acid, pH adjusted to 7.4 with NaOH.
The patch pipette solution contained 145 mM Cs-
methanesulfonate, 20 mM 1,2-bis(2-aminophenoxy)
ethane-N,N,N0,N0-tetraacetic acid (BAPTA), 8 mM
MgCl2, and 10 mM HEPES, pH adjusted to 7.2 with
CsOH. Under these conditions, voltage-dependent
Ca2C channels and Ca2C-activated and swell-activated
Cl¡ conductances are blocked allowing cation conduc-
tances to be recorded in isolation.
In cell-attached patch experiments the membrane
potential was set to 0 mV by perfusing cells in a KCl
external solution containing (mM): 126 KCl, 1.5 CaCl2,
10 HEPES and 11 glucose, pH adjusted to 7.2 with
10 M KOH. 5 mMNicardipine was included to prevent
smooth muscle cell contraction by blocking Ca2C entry
through voltage-gated Ca2C channels. The patch
pipette solution used for both cell-attached and inside-
out patch recording (extracellular solution) was KC
free and contained (mM): 126 NaCl, 1.5 CaCl2, 10
HEPES, 11 glucose, 10 TEA, 5 4-AP, 0.0002 iberio-
toxin, 0.1 DIDS, 0.1 niﬂumic acid and 0.005 nicardi-
pine, pH adjusted to 7.2 with NaOH. Inside-out patch
bathing solution contained (mM): 18 CsCl, 108 cesium
aspartate, 1.2 MgCl2, 10 HEPES, 11 glucose, 1 Na2ATP,
and 0.2 NaGTP, pH adjusted to 7.2 with Tris. Free
[Ca2C]i was set at 100 nM by adding 0.48 mM CaCl2
plus 1 mM 1,2-bis-(2-aminophenoxy)ethane-N,N,N0,
N0-tetraacetic acid(acetoxymethyl ester) BAPTA) using
EqCal software (Biosoft, Cambridge, UK).
Primary cell culture
VSMCs were seeded into culture plates; maintained
using DMEM/F-12 media containing 1% serum, and
incubated at 37C in 95%O2:5%CO2 at 100% humidity
for up to 7 d. In 1% serum, VSMCs maintained their
contractile phenotype and had similar properties to
TRPC1 channel currents in freshly dispersed
VSMCs,19 which suggest that compensatory changes
to channel properties were unlikely in these cell cul-
ture conditions.
Knockdown of STIM1
We used lentiviral-mediated delivery of pLKO.1-puro
based shRNA expression plasmids purchased from
Sigma-Aldrich to knockdown STIM1 (Gillingham,
UK). Infected VSMCs were selected with 2.5 mg/ml
puromycin (Invitrogen, San Diego, US) for 2 d before
the experiments, and STIM1 levels were determined
by Western blotting. STIM1 shRNA sequence used to
knockdown STIM1 in mice was 50-CACCTTC-
CATGGTGAGGATAA-30.20 Scrambled STIM1
shRNA sequence was used as a control.
Imaging of GFP-PLCd-PH-mediated signals
VSMCs were transfected with GFP-PLCd-PH (Addg-
ene (plasmid ID:21179, Addgene) using Nucle-
ofectorTM according to manufacturer’s instructions
(Amaxa Biosystems, Gaithersburg, MD). 0.2–0.4 mg
plasmid DNA was added to 1£105 cells re-suspended
in 20 ml NucleofectorTM solution, and cells were kept
in primary cell culture conditions for up to 3 d. Trans-
fected cells were imaged using a Zeiss LSM 510 laser
scanning confocal microscope and associated software
(Carl Zeiss, Jena, Germany). Excitation was produced
by 488/405 nm lasers and delivered via a Zeiss Apo-
chromat 63 oil-immersion objective (numerical aper-
ture, 1.4). Two-dimensional images cut horizontally
through approximately the middle of the cells were
captured (1024£1024 pixels). Final images were pro-
duced using PowerPoint (Microsoft XP;Microsoft,
Richmond, WA, USA).
Immunocytochemistry
Freshly isolated VSMCs were ﬁxed with 4% parafor-
maldehyde (Sigma-Aldrich, Gillingham, UK) for
10 min, washed with phosphate-buffered saline (PBS),
and permeabilised with PBS containing 0.1% Triton
X-100 for 20 min at room temperature. Cells were
incubated with PBS containing 1% bovine serum albu-
min (BSA) for 1 h at room temperature and then were
incubated with primary antibodies in PBS containing
1% BSA overnight at 4C. The cells were washed and
incubated with secondary antibodies conjugated to a
ﬂuorescent probe. Unbound secondary antibodies
were removed by washing with PBS, and nuclei were
labeled with 40,6-diamidino-2-phenylindole (DAPI)
mounting medium (Sigma-Aldrich). Cells were
imaged using a Zeiss LSM 510 laser scanning confocal
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microscope (Carl Zeiss, Jena, Germany). The excita-
tion beam was produced by an argon (488nm) or
helium/neon laser (543 nm and 633 nm), and deliv-
ered to the specimen via a Zeiss Apochromat X63 oil
immersion objective (numerical aperture, 1.4). Emit-
ted ﬂuorescence was captured using LSM 510 software
(release 3.2; Carl Zeiss). Two-dimensional images cut
horizontally through approximately the middle of the
cells were captured (1024£1024 pixels). Raw confocal
imaging data were processed and analyzed using Zeiss
LSM 510 software. Final images were produced using
PowerPoint (Microsoft XP;Microsoft, Richmond,
WA, USA).
Statistical analysis
This was performed using paired (comparing the
effects of agents on the same cell) or unpaired (com-
paring the effects of agents between cells) Student’s t
tests with the level of signiﬁcance set at a value of P <
0.05.
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